000 01366 a2200421 4500
005 20250516013342.0
264 0 _c20120314
008 201203s 0 0 eng d
022 _a1476-5365
024 7 _a10.1038/bmt.2010.285
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFontanet, A
245 0 0 _aCotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal.
_h[electronic resource]
260 _bBone marrow transplantation
_cSep 2011
300 _a1272-3 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Infective Agents
_xadverse effects
650 0 4 _aBlood Platelets
_xphysiology
650 0 4 _aCase-Control Studies
650 0 4 _aFemale
650 0 4 _aHematologic Diseases
_xblood
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeutrophils
_xphysiology
650 0 4 _aTrimethoprim, Sulfamethoxazole Drug Combination
_xadverse effects
650 0 4 _aYoung Adult
700 1 _aChalandon, Y
700 1 _aRoosnek, E
700 1 _aMohty, B
700 1 _aPassweg, J R
773 0 _tBone marrow transplantation
_gvol. 46
_gno. 9
_gp. 1272-3
856 4 0 _uhttps://doi.org/10.1038/bmt.2010.285
_zAvailable from publisher's website
999 _c20396013
_d20396013